EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 6.5

ph-index = 6

Forward Citations = 148(Granted Patents)

Company Filing History:

Kaken Pharmaceutical Company, Ltd.

patents

4. 4 out of 4

Molecular Research Institute

patents

where one patent can have more than one assignee

Years Active: 2002-2012

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8324231 - Pyrimidinones as casein kinase II (CK2) modulators (2012-12-04),

2. 8242129 - 6-phenylpyrimidinones as PIM modulators (2012-08-14),

3. 8163771 - 11 β-HSD1 modulators (2012-04-24),

4. 8076338 - Kinase modulators and methods of use (2011-12-13),

5. 7279573 - Amide derivatives (2007-10-09),

6. 7186832 - Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors (2007-03-06),

7. 7186716 - 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors (2007-03-06),

8. 7157460 - Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors (2007-01-02),

9. 7122548 - Triazolotriazine compounds and uses thereof (2006-10-17),

10. 7064121 - N-acylated lipophilic amino acid derivatives (2006-06-20),

11. 7053086 - 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors (2006-05-30),

12. 7022677 - Amide derivatives as growth hormone secretagogues (2006-04-04),

13. 6864250 - N-acylated lipophilic amino acid derivatives (2005-03-08),

14. 6635640 - 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors (2003-10-21),

15. 6596772 - Phosphate mimics and methods of treatment using phosphatase inhibitors (2003-07-22),

Title: The Innovative Contributions of Ping Huang

Introduction

Ping Huang is a notable inventor based in Mountain View, CA, with a remarkable portfolio of 16 patents. His work primarily focuses on the development of pharmaceutical compounds that target specific biological pathways, showcasing his expertise in medicinal chemistry.

Latest Patents

Among his latest patents, Huang has developed pyrimidinones as casein kinase II (CK2) modulators. These compounds, defined by a specific formula, serve as inhibitors of the CK2 pathways, which are crucial in various cellular processes. Additionally, he has worked on 6-phenylpyrimidinones as PIM modulators, which also involve unique chemical formulations and have potential therapeutic applications.

Career Highlights

Throughout his career, Ping Huang has made significant contributions to the pharmaceutical industry. He has worked with prominent companies such as Sugen Incorporated and Exelixis, Inc., where he has applied his innovative ideas to advance drug development.

Collaborations

Huang has collaborated with talented individuals in his field, including Chung Chen Wei and Peng Cho Tang. These partnerships have likely enhanced his research and contributed to the success of his projects.

Conclusion

Ping Huang's innovative work in the field of pharmaceuticals has led to the development of important compounds that may have significant therapeutic implications. His contributions continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com

2 patents pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.